colforsin has been researched along with Hepatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fischer, W; Schudt, C; Wendel, A | 1 |
| Mashiba, H; Mitani, Y; Shigemasa, C; Taniguchi, S; Ueta, Y; Urabe, K; Yoshida, A | 1 |
2 other study(ies) available for colforsin and Hepatitis
| Article | Year |
|---|---|
Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice.
Topics: Animals; Cells, Cultured; Colforsin; Cyclic AMP; Dinoprostone; Galactosamine; Hepatitis; Lipopolysaccharides; Liver; Macrophages; Male; Mice; Phosphodiesterase Inhibitors; Pyridazines; Pyrrolidinones; Rolipram; Shock, Septic; Tumor Necrosis Factor-alpha | 1993 |
The mechanism involved in the conversion of thyrotropin receptor-bound blocking-type immunoglobulin G (IgG) to the stimulating-type by anti-human IgG antibodies.
Topics: Adult; Aged; Antibodies, Anti-Idiotypic; Autoimmune Diseases; Cells, Cultured; Colforsin; Cyclic AMP; Female; Hepatitis; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Microsomes; Middle Aged; Receptors, Thyrotropin; Rheumatoid Factor; Thyroid Gland; Thyrotropin | 1990 |